Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	question first answered answering member label
creator	label
publisher	pref label
tabling member	label

Search

91630

	human indexable
	published
	registered interest
	answer date	13/10/2014
	date	11/09/2014
	date tabled	11/09/2014
	ddp created	11/09/2014 19:01:04
	ddp modified	07/02/2015 23:10:08
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	209135
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	13/10/2014 14:19:49
	question text	To ask the Secretary of State for Health, with reference to the Government response to the consultation on draft regulations to permit the use of new treatment techniques to prevent the transmission of a serious mitochondrial disease from mother to child, published in July 2014, whether his Department consulted (a) Dr Andy Greenfield, (b) Professor Peter Braude and (c) Professor Robin Lovell-Badge on the formulation of the statement on page 15 that (i) mitochondrial donation techniques do not alter personal characteristics and traits of the person and (ii) the proposed mitochondrial donation techniques do not constitute genetic modification.
	session	2014/15
	session number	4
	tabling member constituency	Stoke-on-Trent South
	tabling member printed	Robert Flello
	title	House of Commons Tabled Parliamentary Question 2014/15 209135
	type	WrittenParliamentaryQuestion
	uin	209135
	version	1
	written parliamentary question type	NamedDay
	answer	answer question first answered 13/10/2014 14:19:49 answering member 4020 label Biography information for George Freeman
	creator	1569 label Biography information for Robert Flello
	publisher	25259 pref label House of Commons
	tabling member	1569 label Biography information for Robert Flello

179004

	human indexable
	published
	registered interest
	answer date	23/02/2015
	date	10/02/2015
	date tabled	10/02/2015
	ddp created	11/02/2015 00:23:16
	ddp modified	23/02/2015 16:37:09
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hereditary Diseases
	house id	1
	identifier	224080
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	23/02/2015 16:05:17
	question text	To ask the Secretary of State for Health, with reference to Part 5 (a) (ii) of the Mitochndrial Donation Regulations 2015, how the Human Fertilisation and Embryology Authority plans to define a "significant risk" of having or developing serious mitochondrial disease.
	session	2014/15
	session number	4
	tabling member constituency	Stoke-on-Trent South
	tabling member printed	Robert Flello
	title	House of Commons Tabled Parliamentary Question 2014/15 224080
	type	WrittenParliamentaryQuestion
	uin	224080
	version	1
	written parliamentary question type	NamedDay
	answer	answer question first answered 23/02/2015 16:05:17 answering member 3918 label Biography information for Jane Ellison
	creator	1569 label Biography information for Robert Flello
	publisher	25259 pref label House of Commons
	tabling member	1569 label Biography information for Robert Flello